You need to upgrade your Flash Player

HansaBioMed has designed a new ExoTESTTM specific for quantification of exosomes from human SERUM.

HBM provides also several ExoTESTTM kits for quantification of overall or specific exosome populations from human biofluids (plasma, urine) and from cell culture supernatants. Click here for the list of available ExoTESTTMquantification kits.

ExoTESTTM are also available with specific immunoplates for colorimetric (transparent), luminometric (white) or fluorimetric (black) readings.

Customized ExoTESTTM kits can be provided for special research needs or for OEM productions.

Lyophilized Exosome Standards are in promotion (-25% Discount) for the whole month of March. Click here for ordering.

Antibodies are an essential tool for basic research, development of diagnostic tests and therapeutics for human disease. Extracellular vesicles (EVs), including exosomes, express antigens with 3D conformations and/or post-translational modifications that often differ from the cellular counterpart. For this reason, most of the antibodies currently available on the market fail to recognize exosome-associated antigens with sufficient sensitivity and specificity. HansaBioMed has validated a list of polyclonal and monoclonal antibodies against common (CD63, CD81, ALIX) and disease- specific (cancer and neurodegenerative diseases) exosome markers.

HansaBioMed will be Bronze Sponsorship at the Annual Meeting 2015 of ISEV (International Society for Extracellular Vesicles), 23-26 April 2015, Washington DC, USA.

Come and visit us at our stand!

HansaBioMed increases the list of its Lyophilized Exosome Standards from Human Biofluids with purified exosomes from Human SERUM and SALIVA of certified healthy donor pools.

Exosome isolation is obtained through a combination of ultracentrifugation and microfiltration procedures. Exosomes are subsequently quantified and validated for overall protein content and particle number by Nanoparticles Tracking Analysis with NanoSight. Lyophilization allows long term storage at 4°C (up to 36 months) and does not modify the properties of exosome proteins or nucleic acids.

Click here for the list of available Lyophilized Exosome Standards from human biofluids

EXO-Prep is in promotion for the whole month of January (-25% Discount)

EXO-Prep is a new and efficient method for exosome isolation from biofluids (i.e. plasma serum and urine) and from cell culture supernatants. Exosomes are quickly isolated from your sample by an incubation step with EXO-Prep precipitation reagent. Exosome pellet is subsequently collected by one-step centrifugation and can be easily resuspended in PBS 1X. Solubilized exosomes are suitable for different downstream analyses such as proteomic or nucleic acids marker profiling, NTA, electron microscopy etc.

Contract Research



We develop special ad hoc contract research projects to provide solutions to specific needs coming from our clients. We conduct contract pilot studies in unexplored areas to test feasibility of specific exosomes based applications in basic and clinical research.


Contact us...

Collaborative Projects

03 Polymerphysik03

We encourage collaborative projects with other entities (companies, academies, research centers) under different schemes and the creation of consortia aiming at rising complementary funding to develop specific applied research or R&D activities of common interest.


Contact us...

Apply Exosomes to my Product

Area Life Sciences 3

We conduct special ad hoc feasibility studies aiming at determining if exosomes based technologies or solutions can be applied to improve products or processes of a company, complemented by proof-of-concept pilot studies to consolidate the potentials of the proposed solutions.


Contact us...

Technological Services

Pilt tehnol

We provide consultancy and technological services (such as but not limited to sample preparation, sample analysis and characte-rization, specific training, etc.) applying HansaBioMed´s techniques and know how in exosomes manipulation and analysis.


Contact us...